Navigation Links
Bloomberg BNA Publishes Sixth Edition of False Claims Act Treatise
Date:3/1/2013

ARLINGTON, Va., March 1, 2013 /PRNewswire-USNewswire/ -- Bloomberg BNA has published the Sixth Edition of False Claims Act: Whistleblower Litigation, providing guidance and analysis of the False Claims Act (FCA) and the many different legislative developments and judicial opinions surrounding it, including qui tam cases in which a private citizen assists in a government prosecution and is paid a percentage of the recovery. Written by the trial lawyer called to testify before Congress on ways to modernize, update, and streamline the FCA, this treatise offers authoritative insights from one of the country's most experienced FCA lawyers.

(Logo: http://photos.prnewswire.com/prnh/20120110/DC33627LOGO)  

In False Claims Act: Whistleblower Litigation, Sixth Edition, practitioners will find discussion of:

  • Pharmaceutical company liability
  • Circuit-by-circuit analysis of Civil Rule 9(b) to FCA complaints
  • Bankruptcy proceedings
  • Statute of limitations for whistleblower employment protections
  • Identifying alternate proceedings
  • Disclosure of defendants' fee information
  • Settlement challenges by realtors, non-settling defendants, and the government
  • State and municipal FCA statutes

Since publication of the Fifth Edition in 2007 by Top Gun Publishing LLC (Cincinnati, Ohio), Congress has amended the FCA three times and the courts have issued more than 2,000 opinions related to the Act. These amendments are fully examined and explained in the Sixth Edition, as are the sometimes conflicting court opinions that have resulted in procedural minefields and other obstacles to proving liability. The Sixth Edition also includes a chapter that details all U.S. Supreme Court opinions related to the Act; a chapter on the numerous state FCAs that have been enacted; and a comprehensive, searchable collection of appendices that provide more than 40 letters, complaints, statements, interrogatories, requests, motions, and affidavits.

With the Sixth Edition, practitioners have all the model forms and procedures needed to effectively litigate qui tam cases. The treatise also includes a table of cases and all versions of this statute and its legislative history, providing a quick reference for both plaintiff and defense attorneys. The Sixth Edition also provides samples of motions in limine used in recent cases; HIPAA and PHSA complaint protective orders; United States Bankruptcy Court Proof of Claim and Application of Trustee to Employ Special Counsel; attorneys' fees and costs application, declaration of counsel, and affidavit in support of an expert; and jury instructions, special interrogatories, and verdict form.

False Claims Act: Whistleblower Litigation, Sixth Edition is authored by James B. Helmer, Jr. , a Senior Partner and President of Helmer, Martins, Rice & Popham Co., L.P.A., in Cincinnati, Ohio. The previous edition was published by Top Gun Publishing LLC (Cincinnati, Ohio). This treatise is available for sale directly from Bloomberg BNA and also will be available on the Bloomberg Law legal research system.

Bloomberg BNA, a wholly owned subsidiary of Bloomberg, is a leading source of legal, regulatory, and business information for professionals. In addition to False Claims Act: Whistleblower Litigation, Bloomberg BNA publishes: Director and Officer Liability in Financial Institutions: A Deskbook; Criminal Tax, Money Laundering, and Bank Secrecy Act Litigation; Whistleblowing: The Law of Retaliatory Discharge; and other titles in litigation. Visit us online for a free catalog, call 1.800.960.1220, or send an email request to books@bna.com.

False Claims Act: Whistleblower Litigation may be purchased (1,594 pp. Hardcover, Order #2197-PR12/$395.00 plus tax, shipping, and handling) from Bloomberg BNA, Book Division, PO Box 7814, Edison, NJ 08818-7814. Telephone orders: 1.800.960.1220. Fax orders: 1.732.346.1624. A 10% discount is available on print copies of books when ordering from the website at www.bna.com/bnabooks. Please note that discounts cannot be combined.

Editors: Review copy available upon request.
Please email Anna Bailey at abailey@bna.com, or call 703.341.5767
Follow us on Twitter @BloombergBNA and @annaebailey6


'/>"/>
SOURCE Bloomberg BNA
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New York City Mayor Bloomberg and Health Commissioner Farley Receive Flu Shot at Duane Reade Pharmacy, Highlight Importance of Flu Preparedness
2. HemoShear Publishes Key Review on Human-Relevant Organotypic Systems
3. Obesity journal publishes new study on lorcaserin, a weight-loss medication recommended for approval by FDA advisory panel
4. Epilepsia Publishes Results From Two Studies Of Eisais Perampanel
5. Pharmspective Publishes New Assessment of Impact of State Exchanges on Key Insurers and Pharma
6. American Journal of Obstetrics and Gynecology Publishes PeriGen Research on Shoulder Dystocia
7. American Journal of Medicine Publishes Hypertension Study Comparing the Fixed-Dose Combination of Azilsartan Medoxomil and Chlorthalidone versus Azilsartan Medoxomil Co-administered with Hydrochlorothiazide
8. Varian Medical Systems Publishes 2012 Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements
9. Epizyme Publishes Current Review on Targeting Protein Methyltransferases for Personalized Cancer Therapeutics
10. Express Scripts Publishes Inaugural Drug Trend Quarterly, Provides First Comprehensive Overview of U.S. Prescription Drug Spending for 2012
11. Gynecologic Oncology Publishes New Clinical Study Showing Positive Performance of OVA1, Vermillions Ovarian Cancer Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... , Feb. 4, 2016 Frontier Pharma: ... Commercializing First-in-Class Innovation Chronic Obstructive ... with chronic inflammation of the airways and lungs. ... symptoms make the disease one of the leading ... death in the world. COPD is linked to ...
(Date:2/4/2016)... COLUMBUS, Ohio, Feb. 4, 2016 Mettler-Toledo International ... results for 2015.  Provided below are the highlights: ... the quarter compared with the prior year.  Reported sales ... in the quarter. , Net earnings per diluted ... in the prior- year period.  Adjusted EPS was $4.65, ...
(Date:2/4/2016)... 4, 2016 In response to the opioid abuse ... Commissioner for Medical Products and Tobacco, along with other FDA ... agency,s approach to opioid medications. The plan will focus on ... in pain access to effective relief. ... , Re-examine the risk-benefit paradigm for opioids and ensure that ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... ... After years as an active staff surgeon and having served as the director ... transitioned to chief of the Division of Plastic Surgery at what is now known ... began a second three-year term in January of 2016. , The original selection was ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Regular gym users ... themselves having to wait longer to access the treadmills. It’s a predictable trend. After ... to lose weight and get in shape by joining gyms, starting new walking or ...
(Date:2/5/2016)... ... February 05, 2016 , ... Dr. Justin Scott and Dr. ... Annual No Cost Dental Day to individuals in need. The event is scheduled to ... No Cost Dental Day is to provide dental care to community members in need. ...
(Date:2/5/2016)... ... 05, 2016 , ... Health and wellness is a topic that should concern ... they are experiencing an illness. Migraines are a severe form of a headache and ... would not wish the pain on their worst enemy, the feeling can last for ...
(Date:2/5/2016)... ... 05, 2016 , ... –This week, Atascadero water heater company First Call ... heater. To view the report, click here or see below. , ... their pros and cons, the type chosen is almost entirely up to personal preference. ...
Breaking Medicine News(10 mins):